David Larsen
Stock Analyst at BTIG
(2.03)
# 3,053
Out of 5,122 analysts
98
Total ratings
37.04%
Success rate
-4.06%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFST LifeStance Health Group | Maintains: Buy | $10 → $11 | $7.11 | +54.71% | 3 | Feb 2, 2026 | |
| HIMS Hims & Hers Health | Maintains: Buy | $85 → $60 | $25.54 | +134.93% | 3 | Feb 2, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $50 → $55 | $39.02 | +40.95% | 5 | Feb 2, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $45 → $40 | $21.28 | +87.97% | 3 | Feb 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $3.09 | +223.62% | 8 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Buy | $50 | $44.72 | +11.81% | 1 | Jan 12, 2026 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $15.40 | - | 4 | Dec 18, 2025 | |
| PIII P3 Health Partners | Suspends: Neutral | n/a | $2.02 | - | 3 | Dec 12, 2025 | |
| AGL agilon health | Suspends: Neutral | n/a | $0.76 | - | 2 | Dec 12, 2025 | |
| HQY HealthEquity | Reiterates: Buy | $130 | $82.12 | +58.30% | 5 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $190.80 | +78.20% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $3.18 | +214.47% | 4 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.73 | +156.41% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $9.43 | +59.07% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.19 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $34.85 | +129.56% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $23.24 | +20.48% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $22.01 | +40.85% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $203.77 | +27.59% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.17 | +222.58% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.72 | +874.79% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $46.04 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.43 | +56.04% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.11 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.34 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $218.00 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $851.12 | -81.20% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.14 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $76.83 | +10.63% | 3 | Feb 9, 2018 |
LifeStance Health Group
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $7.11
Upside: +54.71%
Hims & Hers Health
Feb 2, 2026
Maintains: Buy
Price Target: $85 → $60
Current: $25.54
Upside: +134.93%
BrightSpring Health Services
Feb 2, 2026
Maintains: Buy
Price Target: $50 → $55
Current: $39.02
Upside: +40.95%
Astrana Health
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $21.28
Upside: +87.97%
Evolent Health
Feb 2, 2026
Maintains: Buy
Price Target: $16 → $10
Current: $3.09
Upside: +223.62%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $50
Current: $44.72
Upside: +11.81%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $15.40
Upside: -
P3 Health Partners
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.02
Upside: -
agilon health
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.76
Upside: -
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $82.12
Upside: +58.30%
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $190.80
Upside: +78.20%
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.18
Upside: +214.47%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $2.73
Upside: +156.41%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.43
Upside: +59.07%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $34.85
Upside: +129.56%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $23.24
Upside: +20.48%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.01
Upside: +40.85%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $203.77
Upside: +27.59%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.17
Upside: +222.58%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.72
Upside: +874.79%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $46.04
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.43
Upside: +56.04%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.11
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.34
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $218.00
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $851.12
Upside: -81.20%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.14
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $76.83
Upside: +10.63%